Edition:
United Kingdom

People: ArQule Inc (ARQL.OQ)

ARQL.OQ on NASDAQ Stock Exchange Global Market

9.31USD
6:12pm BST
Change (% chg)

$0.38 (+4.26%)
Prev Close
$8.93
Open
$8.93
Day's High
$9.35
Day's Low
$8.90
Volume
168,774
Avg. Vol
743,723
52-wk High
$12.21
52-wk Low
$2.23

Zenner, Patrick 

Mr. Patrick J. Zenner is an Independent Chairman of the Board of the Company. Mr. Zenner was named Chairman of the Board in May 2004 and has been a director since 2002. Mr. Zenner retired in 2001 from the position of President and Chief Executive Officer of Hoffmann-La Roche Inc., North America, based in Nutley, N.J. Mr. Zenner held various executive positions during his 32-year career with the company. Mr. Zenner is currently a member of the Board of Trustees of Creighton University and is Chairman of the Board of Trustees of Fairleigh Dickinson University. In addition, Mr. Zenner is Chairman of the Board of Directors of West Pharmaceutical Services, Inc. and a director at Selecta Bioscience, Inc. Until its sale in 2012, Mr. Zenner was a director of Par Pharmaceuticals, Inc. In 2010, he resigned from the boards of Geron Corporation, Xoma Ltd. and Exact Sciences, Inc. He has a B.S./B.A. from Creighton University and an M.B.A. from Fairleigh Dickinson University.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 110,485
Fiscal Year Total, USD 110,485

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick Zenner

110,485

Peter Lawrence

1,168,540

Paolo Pucci

1,744,530

Marc Schegerin

--

Brian Schwartz

1,057,610

Timothy Barabe

92,438
As Of  31 Dec 2018